NovaBay Pharmaceuticals (NBY) Ownership - Who owns NovaBay Pharmaceuticals?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.7M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
2.42M
Revenue
15.02M
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
53.23 USD as % of share price

Fundamentals

NBY
Capitalization
2.7M
P/E Ratio
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
2.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
53.23%
Revenue
15M
ROE
N/A
Book Value
-1.33M
P/B Ratio
2.22
Cash Flow
N/A
Earnings
-114.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
320K
Current Ratio
0.92
Current Revenue Per Employee
101192.30
Dividends Per Share - Security
N/A
EBITDA
-6.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.19
Revenue To Assets
-183.85
Shares Held By Institutions
48.2K
Shares Outstanding - Current
1.35M
Total Liabilities
5.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-71.989
View a ticker or compare two or three
NBY
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com